In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California Passes Cruelty-Free Cosmetics Act: Now Friendlier To Industry, Still A Legal Minefield

This article is powered by The Rose Sheet

Executive Summary

Late-stage, industry-driven amendments to SB 1249 eliminated terms that could have made companies liable for animal testing entirely outside their control. The bill that passed Aug. 31 is still rife with legal risks for companies that claim exemptions, according to Sacramento-area attorney Angela Diesch.

You may also be interested in...



Canada’s Cosmetic Animal-Testing Ban: What It Means For China Testing, New Ingredients, USA

Canada’s prohibitions on cosmetic animal testing enter into force in December, largely in line with EU, California and other bans around the globe, but with some notable distinctions. “Now it's really time to increase the pressure in the US – action can't be far behind,” says Brandi Halls, chief ethics officer at Lush Cosmetics, North America.

Mexico To Be 41st Country With Cosmetic Animal Testing Ban

Legislation approved by Mexico’s Senate “also bans the manufacture, import and marketing of cosmetics tested on animals elsewhere in the world,” according to Humane Society International. Once ratified, the law will give cosmetics manufacturers two years to bring their operations into compliance.

US FDA Highlights Work To Advance Predictive Toxicology, Non-Animal Testing For Cosmetics

The FDA’s cosmetics office is exploring integrated testing strategies to identify potential skin sensitizers without use of animals, as well as use of in vitro assays to evaluate cosmetic ingredients’ dermal penetration potential. Meanwhile, CFSAN is testing the effects of substances on gene expression in collaboration with other federal agencies as part of Tox21-Phase III.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121809

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel